Basel Medical Group Ltd BMGL

Healthcare SIC 8011 - Services-Offices & Clinics of Doctors of Medicine NAICS Health Care and Social Assistance › Ambulatory Health Care Services derived Nasdaq

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—

Annual financial statements

Income statement

Fiscal year FY2025FY2024
Revenue $8.9M—
Net income -$8.4M—

Balance sheet

Fiscal year FY2025FY2024
Total assets $14.7M—
Total equity $4.3M$5.6M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-009978.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -10M -5M 0 5M 10M Revenue, FY2025: 8.9M Net income, FY2025: -8.4M FY2024 FY2025
Fiscal year FY2024FY2025
Revenue — $8.9M
Gross profit — —
Net income — -$8.4M

Others in SIC 8011

TickerCompanyMarket capP/ERevenue growth
HIMS Hims & Hers Health, Inc. $6.42B 54.3x 59.0%
TDOC Teladoc Health, Inc. $1.15B — -1.5%
STLN Starling Oncology, Inc. $683.9M — 27.8%
SBC SBC Medical Group Holdings Inc $543.0M 10.6x -15.5%
LFMD LifeMD, Inc. $102.7M 8.5x 25.3%
AIRS Airsculpt Technologies, Inc. $86.5M — -15.8%
CCM Concord Medical Services Holdings Ltd — — 26.6%